Dongkook Pharmaceutical Records First-Half Sales of 509.9 Billion Won... Operating Profit Up 12.6%
Double-Digit Growth in Sales, Operating Profit, and Net Profit
Highest First-Half Sales on Record
Centellian24 Second-Quarter Sales Surge 566 Percent
Health Functional Foods Business Grows Over 40 Percent
Dongkook Pharmaceutical announced on August 14 that its consolidated sales in the first half of this year reached 509.9 billion won, with operating profit at 53.4 billion won and net profit at 43.6 billion won. Compared to the same period last year, these figures increased by 11.5%, 12.6%, and 20.9%, respectively, marking the highest first-half sales in the company’s history.
On a standalone basis, sales were 436.5 billion won, operating profit was 47.8 billion won, and net profit was 40.8 billion won, representing year-on-year increases of 16.7%, 23.4%, and 32.9%, respectively.
By business segment, the prescription drug (ETC) business grew by 10.5% year-on-year in the second quarter, with a cumulative first-half growth rate of 9.4%. The over-the-counter (OTC) business also continued to grow, backed by the expansion of brand product lines and a broader general product portfolio.
In the health and beauty segment, the dermacosmetics brand ‘Centellian24’ continued its growth trend. Centellian24’s second-quarter sales increased by 566% compared to the same period last year. As of June, accumulated sales of its flagship product, 'Madeca Cream,' have surpassed 99 million units.
Sales from the health functional foods business in the first half increased by more than 40% year-on-year. 'Myfit' has recorded approximately 47 billion won in cumulative sales since its launch.
The company is also expanding its global business. For example, ‘Uresco’, a combination drug for benign prostatic hyperplasia, has secured a license and supply contract worth a total of 3.9 billion won over the next 10 years with Spanish pharmaceutical company FAES FARMA, covering 13 countries in Central and South America.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Dongkook Pharmaceutical plans to expand its pipeline of new products and businesses through pharmaceuticals developed with DDS (Drug Delivery System) technology and open innovation.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.